272 related articles for article (PubMed ID: 17892982)
1. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.
Lacro RV; Dietz HC; Wruck LM; Bradley TJ; Colan SD; Devereux RB; Klein GL; Li JS; Minich LL; Paridon SM; Pearson GD; Printz BF; Pyeritz RE; Radojewski E; Roman MJ; Saul JP; Stylianou MP; Mahony L;
Am Heart J; 2007 Oct; 154(4):624-31. PubMed ID: 17892982
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
Gambarin FI; Favalli V; Serio A; Regazzi M; Pasotti M; Klersy C; Dore R; Mannarino S; Viganò M; Odero A; Amato S; Tavazzi L; Arbustini E
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
[TBL] [Abstract][Full Text] [Related]
3. Atenolol versus losartan in children and young adults with Marfan's syndrome.
Lacro RV; Dietz HC; Sleeper LA; Yetman AT; Bradley TJ; Colan SD; Pearson GD; Selamet Tierney ES; Levine JC; Atz AM; Benson DW; Braverman AC; Chen S; De Backer J; Gelb BD; Grossfeld PD; Klein GL; Lai WW; Liou A; Loeys BL; Markham LW; Olson AK; Paridon SM; Pemberton VL; Pierpont ME; Pyeritz RE; Radojewski E; Roman MJ; Sharkey AM; Stylianou MP; Wechsler SB; Young LT; Mahony L;
N Engl J Med; 2014 Nov; 371(22):2061-71. PubMed ID: 25405392
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy.
Lacro RV; Guey LT; Dietz HC; Pearson GD; Yetman AT; Gelb BD; Loeys BL; Benson DW; Bradley TJ; De Backer J; Forbus GA; Klein GL; Lai WW; Levine JC; Lewin MB; Markham LW; Paridon SM; Pierpont ME; Radojewski E; Selamet Tierney ES; Sharkey AM; Wechsler SB; Mahony L;
Am Heart J; 2013 May; 165(5):828-835.e3. PubMed ID: 23622922
[TBL] [Abstract][Full Text] [Related]
5. Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.
Teixido-Tura G; Forteza A; Rodríguez-Palomares J; González Mirelis J; Gutiérrez L; Sánchez V; Ibáñez B; García-Dorado D; Evangelista A
J Am Coll Cardiol; 2018 Oct; 72(14):1613-1618. PubMed ID: 30261963
[TBL] [Abstract][Full Text] [Related]
6. The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers.
Möberg K; De Nobele S; Devos D; Goetghebeur E; Segers P; Trachet B; Vervaet C; Renard M; Coucke P; Loeys B; De Paepe A; De Backer J
Int J Cardiol; 2012 Jun; 157(3):354-8. PubMed ID: 21239069
[TBL] [Abstract][Full Text] [Related]
7. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
Chiu HH; Wu MH; Wang JK; Lu CW; Chiu SN; Chen CA; Lin MT; Hu FC
Mayo Clin Proc; 2013 Mar; 88(3):271-6. PubMed ID: 23321647
[TBL] [Abstract][Full Text] [Related]
8. Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial.
Radonic T; de Witte P; Baars MJ; Zwinderman AH; Mulder BJ; Groenink M;
Trials; 2010 Jan; 11():3. PubMed ID: 20067609
[TBL] [Abstract][Full Text] [Related]
9. Recent Clinical Drug Trials Evidence in Marfan Syndrome and Clinical Implications.
Singh MN; Lacro RV
Can J Cardiol; 2016 Jan; 32(1):66-77. PubMed ID: 26724512
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome.
Bhatt AB; Buck JS; Zuflacht JP; Milian J; Kadivar S; Gauvreau K; Singh MN; Creager MA
Vasc Med; 2015 Aug; 20(4):317-25. PubMed ID: 25795452
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial.
van Andel MM; Indrakusuma R; Jalalzadeh H; Balm R; Timmermans J; Scholte AJ; van den Berg MP; Zwinderman AH; Mulder BJM; de Waard V; Groenink M
Eur Heart J; 2020 Nov; 41(43):4181-4187. PubMed ID: 32548624
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial.
Forteza A; Evangelista A; Sánchez V; Teixidó-Turà G; Sanz P; Gutiérrez L; Gracia T; Centeno J; Rodríguez-Palomares J; Rufilanchas JJ; Cortina J; Ferreira-González I; García-Dorado D
Eur Heart J; 2016 Mar; 37(12):978-85. PubMed ID: 26518245
[TBL] [Abstract][Full Text] [Related]
13. Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome.
Van Driest SL; Sleeper LA; Gelb BD; Morris SA; Dietz HC; Forbus GA; Goldmuntz E; Hoskoppal A; James J; Lee TM; Levine JC; Li JS; Loeys BL; Markham LW; Meester JAN; Mital S; Mosley JD; Olson AK; Renard M; Shaffer CM; Sharkey A; Young L; Lacro RV; Roden DM
J Pediatr; 2020 Jul; 222():213-220.e5. PubMed ID: 32586526
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes.
Sandor GG; Alghamdi MH; Raffin LA; Potts MT; Williams LD; Potts JE; Kiess M; van Breemen C
Int J Cardiol; 2015 Jan; 179():470-5. PubMed ID: 25465809
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of losartan as add-on therapy to prevent aortic growth and ventricular dysfunction in patients with Marfan syndrome: a randomized, double-blind clinical trial.
Muiño-Mosquera L; De Nobele S; Devos D; Campens L; De Paepe A; De Backer J
Acta Cardiol; 2017 Dec; 72(6):616-624. PubMed ID: 28657492
[TBL] [Abstract][Full Text] [Related]
16. Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome: A Review.
Hofmann Bowman MA; Eagle KA; Milewicz DM
JAMA Cardiol; 2019 Jul; 4(7):702-707. PubMed ID: 31066871
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome.
Selamet Tierney ES; Levine JC; Chen S; Bradley TJ; Pearson GD; Colan SD; Sleeper LA; Campbell MJ; Cohen MS; De Backer J; Guey LT; Heydarian H; Lai WW; Lewin MB; Marcus E; Mart CR; Pignatelli RH; Printz BF; Sharkey AM; Shirali GS; Srivastava S; Lacro RV;
J Am Soc Echocardiogr; 2013 Jun; 26(6):657-66. PubMed ID: 23582510
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome.
Mah DY; Sleeper LA; Crosson JE; Czosek RJ; Love BA; McCrindle BW; Muiño-Mosquera L; Olson AK; Pilcher TA; Tierney ESS; Shah MJ; Wechsler SB; Young LT; Lacro RV
Am J Cardiol; 2018 Oct; 122(8):1429-1436. PubMed ID: 30115424
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome.
Hoskoppal A; Menon S; Trachtenberg F; Burns KM; De Backer J; Gelb BD; Gleason M; James J; Lai WW; Liou A; Mahony L; Olson AK; Pyeritz RE; Sharkey AM; Stylianou M; Wechsler SB; Young L; Levine JC; Tierney ESS; Lacro RV; Bradley TJ;
Pediatr Cardiol; 2018 Oct; 39(7):1453-1461. PubMed ID: 29948025
[TBL] [Abstract][Full Text] [Related]
20. Atenolol versus Losartan in Marfan's Syndrome.
Mallat Z; Tedgui A
N Engl J Med; 2015 Mar; 372(10):980. PubMed ID: 25738683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
